Kymera Therapeutics KYMR Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's total liabilities?
- Kymera Therapeutics (KYMR) reported total liabilities of $129.38M in Q1 2026.
- How has Kymera Therapeutics's total liabilities changed year-over-year?
- Kymera Therapeutics's total liabilities decreased by 2.0% year-over-year, from $132.08M to $129.38M.
- What is the long-term trend for Kymera Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Kymera Therapeutics's total liabilities has grown at a -4.3% compound annual growth rate (CAGR), from $203.29M to $163.15M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.